Role of the CDKN2A locus in patients with multiple primary melanomas.
about
Main roads to melanomaUpdate in genetic susceptibility in melanomaCapturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancerGenetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family.The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developmentsAssociation of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.Clinical and Histopathological Characteristics between Familial and Sporadic Melanoma in Barcelona, Spain.Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanomaSelection criteria for genetic assessment of patients with familial melanomaBenefits of oral Polypodium Leucotomos extract in MM high-risk patientsGenetic counseling in melanoma.NF-kappaB activation in melanoma.High- and low-penetrance cutaneous melanoma susceptibility genes.Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?Issues affecting molecular staging in the management of patients with melanomaFeatures associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Genome-wide association study identifies three loci associated with melanoma riskSignificance of CDKN2A gene A148T variant in patients with bladder cancer.Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients.The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil.Multiple primary melanomas: do they look the same?CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic study.Malignant and benign tumors associated with multiple primary melanomas: just the starting block for the involvement of MITF, PTEN and CDKN2A in multiple cancerogenesis?The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.Genotype analysis in Hungarian patients with multiple primary melanoma.The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health StudyMolecular alterations at chromosome 9p21 in melanocytic naevi and melanomaSingle versus multiple primary melanomas
P2860
Q21245465-26B8D6DF-2C03-4421-82EB-B65C830075F7Q26778756-4CD354EB-6431-4844-BB2C-C03A029EF4CEQ28238393-9A6E7D20-26FF-4783-8735-42C457405ACFQ33728131-453E4CBB-CF7E-4842-A3C5-A52031075DBAQ34202289-8BCD6A70-AE5D-4204-947C-4108092A0DEDQ34212766-00AFD875-E41C-4252-A896-AD75BC91F660Q34602917-636CC68A-591F-46F3-90B3-2668B817CF08Q35180844-FB99D766-1F25-4AF8-90EE-71AF31421B41Q35392953-190425DA-0486-403B-A518-4CAAA6515C05Q35446785-EC06CB3D-DD11-4683-8B3D-3217E55CE7F3Q35549114-33107404-0C84-447B-9989-E8EC155A9228Q35840024-AA7AD7E6-6312-4209-BD44-920A5ABA16AAQ36015428-166BF595-B4F6-4B71-A703-4C1C853BBF90Q36314787-1DE20506-33FE-4630-A864-8E3327D1CB0CQ36416479-06A0E3B1-80AF-4187-B3B9-0ECD78D1AEB0Q36499211-E13F07EA-2828-4633-9D8E-925B251F1579Q36768291-E8EE4FAA-045D-4B7A-92EA-3D27C4B95E53Q36843805-2081B91D-1611-4EA6-B2FD-C482920949C8Q36990701-C213DA6C-96C5-4088-A6CF-1FBACB931377Q37004819-1C05CFD7-BA0F-4732-828D-D8D90F3E0E7EQ37083946-81B0759B-ACF6-4556-AE89-4A485DB8346EQ37341178-CA988E62-4FE2-476B-866C-7FF3E248F120Q37579066-90675147-BC3C-4B9A-B1D0-B27B1323E55EQ38242004-E6D5EB5D-6BC6-473E-9976-A60B4DB923E8Q40510567-A89AC0D9-DF13-4C08-9040-CBA332259452Q41827249-85DA3E71-AE94-4736-A070-C15203E3790EQ45381658-E1CFF8C2-669A-4F9D-8201-79D9FCF3460EQ45714638-A53D6981-C7D9-428A-9699-66192B73ADA6Q50635100-F2E39839-B30C-48C6-9C24-3AF9A274E7D2Q50876968-98A691EB-6252-4E1B-8A29-A1D37F5B8309Q51731270-F19B0856-BAD1-46EA-A37E-6F2C14C650EEQ54365351-34DDFFFC-E1BC-4DFE-8ADA-D80B3DFB2BCBQ57253531-EC6BBD5C-445E-4CD2-8D87-088532566169Q57781575-542843BC-0224-428D-9051-DD9AA54190C3Q59228748-1464148A-0922-4E4E-8D6D-61D827566018
P2860
Role of the CDKN2A locus in patients with multiple primary melanomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of the CDKN2A locus in patients with multiple primary melanomas.
@en
Role of the CDKN2A locus in patients with multiple primary melanomas.
@nl
type
label
Role of the CDKN2A locus in patients with multiple primary melanomas.
@en
Role of the CDKN2A locus in patients with multiple primary melanomas.
@nl
prefLabel
Role of the CDKN2A locus in patients with multiple primary melanomas.
@en
Role of the CDKN2A locus in patients with multiple primary melanomas.
@nl
P2093
P50
P356
P1476
Role of the CDKN2A locus in patients with multiple primary melanomas.
@en
P2093
Antoni Azon
Antoni Campoy
Cèlia Badenas
Francisco Cuellar
Joan Brunet-Vidal
Josep Herrero
Rosa Martí
Teresa Castel
Urbá Gonzàlez
P304
P356
10.1200/JCO.2005.08.034
P407
P577
2005-05-01T00:00:00Z